THE SCORECARD

Most drugs never make it in

Small molecules It is often quoted that more than 98% fail to cross the barrier in useful amounts

Large molecules Nearly all antibodies, proteins, and gene therapies are blocked

The exceptions A few small, oily drugs, such as many for epilepsy, depression, and pain, do cross

Crossing the barrier is the exception, not the rule.

A SIZE LIMIT

Where the line falls

Passive diffusion works best below roughly 400 to 500 daltons. Many modern drugs, and every antibody, are far larger.

Biology's favorite drug targets are often on the wrong side of the line.

WHO IS AFFECTED

Brain diseases with few good options

🎗️

Brain tumors

Chemotherapy often struggles to reach tumor cells behind an intact barrier

🧩

Alzheimer's

Only a small fraction of an injected antibody reaches the brain, often under 1%

🦠

Infections

Some antibiotics and antivirals enter the brain poorly

The more precise the drug, the more it needs a way across.

THE COST OF FINDING OUT LATE

A great drug in a dish can fail in a patient

A compound can bind its target perfectly in a lab test and still fail because it never reaches the brain. Learning that late wastes years and money, so early tests of barrier crossing are valuable.

Test crossing early, and test it in something that behaves like a human barrier.

WAYS AROUND

Four strategies

🔑

Shuttles

Attach the drug to something that binds a transport receptor and rides across

🔊

Open briefly

Focused ultrasound with microbubbles can loosen the barrier for a short time

💉

Bypass

Inject directly into the brain or the fluid around it

✏️

Redesign

Make the drug smaller or more fat-soluble

Every strategy needs a way to measure whether it actually worked.

UNIT 5 STUDY COMPLETE

💊

Ready for the Fab Challenge?

You've seen why the barrier blocks most drugs and why testing crossing early matters.